| UniProt ID | DNJC7_HUMAN | |
|---|---|---|
| UniProt AC | Q99615 | |
| Protein Name | DnaJ homolog subfamily C member 7 | |
| Gene Name | DNAJC7 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 494 | |
| Subcellular Localization | Cytoplasm . Nucleus . Cytoplasm, cytoskeleton . Colocalizes with NR1I3 to microtubules. | |
| Protein Description | Acts as co-chaperone regulating the molecular chaperones HSP70 and HSP90 in folding of steroid receptors, such as the glucocorticoid receptor and the progesterone receptor. Proposed to act as a recycling chaperone by facilitating the return of chaperone substrates to early stages of chaperoning if further folding is required. In vitro, induces ATP-independent dissociation of HSP90 but not of HSP70 from the chaperone-substrate complexes. Recruits NR1I3 to the cytoplasm (By similarity).. | |
| Protein Sequence | MAAAAECDVVMAATEPELLDDQEAKREAETFKEQGNAYYAKKDYNEAYNYYTKAIDMCPKNASYYGNRAATLMMLGRFREALGDAQQSVRLDDSFVRGHLREGKCHLSLGNAMAACRSFQRALELDHKNAQAQQEFKNANAVMEYEKIAETDFEKRDFRKVVFCMDRALEFAPACHRFKILKAECLAMLGRYPEAQSVASDILRMDSTNADALYVRGLCLYYEDCIEKAVQFFVQALRMAPDHEKACIACRNAKALKAKKEDGNKAFKEGNYKLAYELYTEALGIDPNNIKTNAKLYCNRGTVNSKLRKLDDAIEDCTNAVKLDDTYIKAYLRRAQCYMDTEQYEEAVRDYEKVYQTEKTKEHKQLLKNAQLELKKSKRKDYYKILGVDKNASEDEIKKAYRKRALMHHPDRHSGASAEVQKEEEKKFKEVGEAFTILSDPKKKTRYDSGQDLDEEGMNMGDFDPNNIFKAFFGGPGGFSFEASGPGNFFFQFG | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAAAECDV ------CCCHHCCCE | 13.05 | 22814378 | |
| 25 | Ubiquitination | LLDDQEAKREAETFK HCCHHHHHHHHHHHH | 50.44 | 24816145 | |
| 32 | Acetylation | KREAETFKEQGNAYY HHHHHHHHHHHCCEE | 57.45 | 25953088 | |
| 32 | Malonylation | KREAETFKEQGNAYY HHHHHHHHHHHCCEE | 57.45 | 26320211 | |
| 38 | Phosphorylation | FKEQGNAYYAKKDYN HHHHHCCEEECCCHH | 14.14 | 25839225 | |
| 39 | Phosphorylation | KEQGNAYYAKKDYNE HHHHCCEEECCCHHH | 14.99 | 28102081 | |
| 41 | 2-Hydroxyisobutyrylation | QGNAYYAKKDYNEAY HHCCEEECCCHHHHH | 30.01 | - | |
| 41 | Ubiquitination | QGNAYYAKKDYNEAY HHCCEEECCCHHHHH | 30.01 | 21906983 | |
| 42 | Ubiquitination | GNAYYAKKDYNEAYN HCCEEECCCHHHHHH | 58.22 | 22817900 | |
| 48 | Phosphorylation | KKDYNEAYNYYTKAI CCCHHHHHHHHHHHH | 9.49 | - | |
| 50 | Phosphorylation | DYNEAYNYYTKAIDM CHHHHHHHHHHHHHH | 10.39 | 19658100 | |
| 51 | Phosphorylation | YNEAYNYYTKAIDMC HHHHHHHHHHHHHHC | 9.72 | - | |
| 53 | Acetylation | EAYNYYTKAIDMCPK HHHHHHHHHHHHCCC | 27.50 | 26051181 | |
| 53 | Ubiquitination | EAYNYYTKAIDMCPK HHHHHHHHHHHHCCC | 27.50 | 32015554 | |
| 60 | Acetylation | KAIDMCPKNASYYGN HHHHHCCCCCHHCHH | 61.28 | 26051181 | |
| 60 | Ubiquitination | KAIDMCPKNASYYGN HHHHHCCCCCHHCHH | 61.28 | 23000965 | |
| 71 | Phosphorylation | YYGNRAATLMMLGRF HCHHHHHHHHHHHHH | 17.75 | 20068231 | |
| 72 | Ubiquitination | YGNRAATLMMLGRFR CHHHHHHHHHHHHHH | 1.30 | 27667366 | |
| 81 | Ubiquitination | MLGRFREALGDAQQS HHHHHHHHHHCHHHH | 16.76 | 21963094 | |
| 94 | Phosphorylation | QSVRLDDSFVRGHLR HHHCCCCHHHHHHCC | 25.88 | 21815630 | |
| 97 | Methylation | RLDDSFVRGHLREGK CCCCHHHHHHCCCCC | 25.46 | - | |
| 99 | Ubiquitination | DDSFVRGHLREGKCH CCHHHHHHCCCCCEE | 15.91 | 27667366 | |
| 104 | Ubiquitination | RGHLREGKCHLSLGN HHHCCCCCEECCHHH | 17.46 | 22817900 | |
| 123 | Ubiquitination | CRSFQRALELDHKNA HHHHHHHHHHCCCCH | 7.96 | 22817900 | |
| 126 | Ubiquitination | FQRALELDHKNAQAQ HHHHHHHCCCCHHHH | 41.14 | 21890473 | |
| 126 | Ubiquitination | FQRALELDHKNAQAQ HHHHHHHCCCCHHHH | 41.14 | 21890473 | |
| 128 | 2-Hydroxyisobutyrylation | RALELDHKNAQAQQE HHHHHCCCCHHHHHH | 54.36 | - | |
| 128 | Acetylation | RALELDHKNAQAQQE HHHHHCCCCHHHHHH | 54.36 | 23749302 | |
| 128 | Ubiquitination | RALELDHKNAQAQQE HHHHHCCCCHHHHHH | 54.36 | 21906983 | |
| 137 | Acetylation | AQAQQEFKNANAVME HHHHHHHHHHHHHHH | 55.16 | 25953088 | |
| 137 | Ubiquitination | AQAQQEFKNANAVME HHHHHHHHHHHHHHH | 55.16 | 21906983 | |
| 145 | Phosphorylation | NANAVMEYEKIAETD HHHHHHHHHHHHCCC | 12.39 | 27642862 | |
| 151 | Phosphorylation | EYEKIAETDFEKRDF HHHHHHCCCCCCCCH | 36.65 | - | |
| 155 | 2-Hydroxyisobutyrylation | IAETDFEKRDFRKVV HHCCCCCCCCHHHHH | 58.21 | - | |
| 155 | Acetylation | IAETDFEKRDFRKVV HHCCCCCCCCHHHHH | 58.21 | 23749302 | |
| 155 | Methylation | IAETDFEKRDFRKVV HHCCCCCCCCHHHHH | 58.21 | - | |
| 155 | Ubiquitination | IAETDFEKRDFRKVV HHCCCCCCCCHHHHH | 58.21 | 21906983 | |
| 160 | Ubiquitination | FEKRDFRKVVFCMDR CCCCCHHHHHHCHHH | 42.62 | 22817900 | |
| 175 | S-nitrosocysteine | ALEFAPACHRFKILK HHHHHHHHHHHHHHH | 2.00 | - | |
| 175 | Glutathionylation | ALEFAPACHRFKILK HHHHHHHHHHHHHHH | 2.00 | 22555962 | |
| 175 | S-nitrosylation | ALEFAPACHRFKILK HHHHHHHHHHHHHHH | 2.00 | 19483679 | |
| 179 | Ubiquitination | APACHRFKILKAECL HHHHHHHHHHHHHHH | 47.27 | 22817900 | |
| 182 | Acetylation | CHRFKILKAECLAML HHHHHHHHHHHHHHH | 45.68 | 25953088 | |
| 182 | Ubiquitination | CHRFKILKAECLAML HHHHHHHHHHHHHHH | 45.68 | 21906983 | |
| 185 | Glutathionylation | FKILKAECLAMLGRY HHHHHHHHHHHHCCC | 3.33 | 22555962 | |
| 188 | Sulfoxidation | LKAECLAMLGRYPEA HHHHHHHHHCCCHHH | 2.35 | 21406390 | |
| 189 | Ubiquitination | KAECLAMLGRYPEAQ HHHHHHHHCCCHHHH | 2.69 | 24816145 | |
| 192 | Phosphorylation | CLAMLGRYPEAQSVA HHHHHCCCHHHHHHH | 12.02 | 22798277 | |
| 197 | Phosphorylation | GRYPEAQSVASDILR CCCHHHHHHHHHHHC | 27.05 | 22798277 | |
| 200 | Phosphorylation | PEAQSVASDILRMDS HHHHHHHHHHHCCCC | 24.03 | 22798277 | |
| 207 | Phosphorylation | SDILRMDSTNADALY HHHHCCCCCCCCHHH | 17.76 | 21815630 | |
| 212 | Ubiquitination | MDSTNADALYVRGLC CCCCCCCHHHHHHHH | 9.81 | 22817900 | |
| 217 | Ubiquitination | ADALYVRGLCLYYED CCHHHHHHHHHHHHH | 15.65 | 21963094 | |
| 221 | Phosphorylation | YVRGLCLYYEDCIEK HHHHHHHHHHHHHHH | 12.10 | 29496907 | |
| 222 | Phosphorylation | VRGLCLYYEDCIEKA HHHHHHHHHHHHHHH | 7.73 | 29496907 | |
| 235 | Ubiquitination | KAVQFFVQALRMAPD HHHHHHHHHHHCCCC | 29.53 | 29967540 | |
| 238 | Methylation | QFFVQALRMAPDHEK HHHHHHHHCCCCHHH | 23.41 | - | |
| 239 | Sulfoxidation | FFVQALRMAPDHEKA HHHHHHHCCCCHHHH | 7.07 | 30846556 | |
| 239 | Ubiquitination | FFVQALRMAPDHEKA HHHHHHHCCCCHHHH | 7.07 | 29967540 | |
| 245 | 2-Hydroxyisobutyrylation | RMAPDHEKACIACRN HCCCCHHHHHHHHCC | 45.17 | - | |
| 245 | Acetylation | RMAPDHEKACIACRN HCCCCHHHHHHHHCC | 45.17 | 25953088 | |
| 245 | Ubiquitination | RMAPDHEKACIACRN HCCCCHHHHHHHHCC | 45.17 | 24816145 | |
| 250 | Ubiquitination | HEKACIACRNAKALK HHHHHHHHCCHHHHH | 1.42 | 29967540 | |
| 253 | Ubiquitination | ACIACRNAKALKAKK HHHHHCCHHHHHCCH | 4.52 | 29967540 | |
| 259 | Acetylation | NAKALKAKKEDGNKA CHHHHHCCHHHCCHH | 55.92 | 7628139 | |
| 266 | Ubiquitination | KKEDGNKAFKEGNYK CHHHCCHHHHHCCHH | 25.41 | 32015554 | |
| 268 | Acetylation | EDGNKAFKEGNYKLA HHCCHHHHHCCHHHH | 70.35 | 25953088 | |
| 268 | Ubiquitination | EDGNKAFKEGNYKLA HHCCHHHHHCCHHHH | 70.35 | 22817900 | |
| 272 | Phosphorylation | KAFKEGNYKLAYELY HHHHHCCHHHHHHHH | 20.45 | 29496907 | |
| 273 | Ubiquitination | AFKEGNYKLAYELYT HHHHCCHHHHHHHHH | 30.55 | 21890473 | |
| 273 | Acetylation | AFKEGNYKLAYELYT HHHHCCHHHHHHHHH | 30.55 | 7709805 | |
| 273 | Ubiquitination | AFKEGNYKLAYELYT HHHHCCHHHHHHHHH | 30.55 | 23000965 | |
| 276 | Phosphorylation | EGNYKLAYELYTEAL HCCHHHHHHHHHHHH | 19.53 | 29496907 | |
| 279 | Phosphorylation | YKLAYELYTEALGID HHHHHHHHHHHHCCC | 7.21 | 29496907 | |
| 291 | Ubiquitination | GIDPNNIKTNAKLYC CCCCCCCCCCCEEEE | 37.54 | 29967540 | |
| 295 | Acetylation | NNIKTNAKLYCNRGT CCCCCCCEEEECCCH | 41.90 | 25953088 | |
| 295 | Ubiquitination | NNIKTNAKLYCNRGT CCCCCCCEEEECCCH | 41.90 | 29967540 | |
| 303 | Ubiquitination | LYCNRGTVNSKLRKL EEECCCHHHHHHHHH | 9.42 | 33845483 | |
| 306 | Acetylation | NRGTVNSKLRKLDDA CCCHHHHHHHHHHHH | 47.29 | 23749302 | |
| 306 | Malonylation | NRGTVNSKLRKLDDA CCCHHHHHHHHHHHH | 47.29 | 26320211 | |
| 306 | Ubiquitination | NRGTVNSKLRKLDDA CCCHHHHHHHHHHHH | 47.29 | 29967540 | |
| 308 | Ubiquitination | GTVNSKLRKLDDAIE CHHHHHHHHHHHHHH | 41.02 | 22817900 | |
| 309 | Acetylation | TVNSKLRKLDDAIED HHHHHHHHHHHHHHH | 67.70 | 26051181 | |
| 309 | Ubiquitination | TVNSKLRKLDDAIED HHHHHHHHHHHHHHH | 67.70 | 29967540 | |
| 312 | Ubiquitination | SKLRKLDDAIEDCTN HHHHHHHHHHHHCCC | 60.94 | 21890473 | |
| 312 | Ubiquitination | SKLRKLDDAIEDCTN HHHHHHHHHHHHCCC | 60.94 | 33845483 | |
| 317 | Glutathionylation | LDDAIEDCTNAVKLD HHHHHHHCCCCCCCC | 1.73 | 22555962 | |
| 319 | Ubiquitination | DAIEDCTNAVKLDDT HHHHHCCCCCCCCHH | 49.41 | 32015554 | |
| 322 | Acetylation | EDCTNAVKLDDTYIK HHCCCCCCCCHHHHH | 43.73 | 26051181 | |
| 322 | Ubiquitination | EDCTNAVKLDDTYIK HHCCCCCCCCHHHHH | 43.73 | 23000965 | |
| 324 | Ubiquitination | CTNAVKLDDTYIKAY CCCCCCCCHHHHHHH | 40.25 | 23000965 | |
| 326 | Phosphorylation | NAVKLDDTYIKAYLR CCCCCCHHHHHHHHH | 27.15 | 21815630 | |
| 327 | Phosphorylation | AVKLDDTYIKAYLRR CCCCCHHHHHHHHHH | 13.86 | 28102081 | |
| 328 | Ubiquitination | VKLDDTYIKAYLRRA CCCCHHHHHHHHHHH | 1.92 | 21890473 | |
| 328 | Ubiquitination | VKLDDTYIKAYLRRA CCCCHHHHHHHHHHH | 1.92 | 23000965 | |
| 329 | Acetylation | KLDDTYIKAYLRRAQ CCCHHHHHHHHHHHC | 22.14 | 23236377 | |
| 329 | Ubiquitination | KLDDTYIKAYLRRAQ CCCHHHHHHHHHHHC | 22.14 | 23000965 | |
| 334 | Ubiquitination | YIKAYLRRAQCYMDT HHHHHHHHHCCCCCH | 26.81 | 23000965 | |
| 337 | Glutathionylation | AYLRRAQCYMDTEQY HHHHHHCCCCCHHHH | 2.72 | 22555962 | |
| 342 | Ubiquitination | AQCYMDTEQYEEAVR HCCCCCHHHHHHHHH | 47.07 | 33845483 | |
| 344 | Phosphorylation | CYMDTEQYEEAVRDY CCCCHHHHHHHHHHH | 14.98 | 27642862 | |
| 351 | Phosphorylation | YEEAVRDYEKVYQTE HHHHHHHHHHHHHHH | 13.69 | 27642862 | |
| 355 | Phosphorylation | VRDYEKVYQTEKTKE HHHHHHHHHHHCCHH | 22.30 | 25839225 | |
| 359 | 2-Hydroxyisobutyrylation | EKVYQTEKTKEHKQL HHHHHHHCCHHHHHH | 69.18 | - | |
| 359 | Acetylation | EKVYQTEKTKEHKQL HHHHHHHCCHHHHHH | 69.18 | 23749302 | |
| 359 | Ubiquitination | EKVYQTEKTKEHKQL HHHHHHHCCHHHHHH | 69.18 | 33845483 | |
| 364 | Ubiquitination | TEKTKEHKQLLKNAQ HHCCHHHHHHHHHHC | 43.67 | 22817900 | |
| 366 | Ubiquitination | KTKEHKQLLKNAQLE CCHHHHHHHHHHCHH | 9.79 | 33845483 | |
| 368 | Acetylation | KEHKQLLKNAQLELK HHHHHHHHHHCHHHH | 59.85 | 25953088 | |
| 368 | Ubiquitination | KEHKQLLKNAQLELK HHHHHHHHHHCHHHH | 59.85 | 22817900 | |
| 373 | Ubiquitination | LLKNAQLELKKSKRK HHHHHCHHHHHHHCC | 46.60 | 33845483 | |
| 375 | 2-Hydroxyisobutyrylation | KNAQLELKKSKRKDY HHHCHHHHHHHCCCH | 45.70 | - | |
| 375 | Acetylation | KNAQLELKKSKRKDY HHHCHHHHHHHCCCH | 45.70 | 23749302 | |
| 375 | Ubiquitination | KNAQLELKKSKRKDY HHHCHHHHHHHCCCH | 45.70 | 32015554 | |
| 376 | Ubiquitination | NAQLELKKSKRKDYY HHCHHHHHHHCCCHH | 74.05 | - | |
| 377 | Phosphorylation | AQLELKKSKRKDYYK HCHHHHHHHCCCHHH | 35.78 | 24719451 | |
| 378 | Ubiquitination | QLELKKSKRKDYYKI CHHHHHHHCCCHHHH | 72.80 | 23000965 | |
| 380 | Ubiquitination | ELKKSKRKDYYKILG HHHHHHCCCHHHHHC | 54.54 | 23000965 | |
| 382 | Phosphorylation | KKSKRKDYYKILGVD HHHHCCCHHHHHCCC | 15.08 | 29496907 | |
| 383 | Phosphorylation | KSKRKDYYKILGVDK HHHCCCHHHHHCCCC | 11.16 | 24719451 | |
| 384 | 2-Hydroxyisobutyrylation | SKRKDYYKILGVDKN HHCCCHHHHHCCCCC | 25.81 | - | |
| 384 | Ubiquitination | SKRKDYYKILGVDKN HHCCCHHHHHCCCCC | 25.81 | 23000965 | |
| 386 | Ubiquitination | RKDYYKILGVDKNAS CCCHHHHHCCCCCCC | 4.84 | 33845483 | |
| 387 | Ubiquitination | KDYYKILGVDKNASE CCHHHHHCCCCCCCH | 29.11 | 22817900 | |
| 388 | Ubiquitination | DYYKILGVDKNASED CHHHHHCCCCCCCHH | 9.44 | 22817900 | |
| 390 | Acetylation | YKILGVDKNASEDEI HHHHCCCCCCCHHHH | 52.59 | 25953088 | |
| 390 | Ubiquitination | YKILGVDKNASEDEI HHHHCCCCCCCHHHH | 52.59 | 23000965 | |
| 393 | Phosphorylation | LGVDKNASEDEIKKA HCCCCCCCHHHHHHH | 55.78 | 28102081 | |
| 398 | Ubiquitination | NASEDEIKKAYRKRA CCCHHHHHHHHHHHH | 29.33 | 33845483 | |
| 399 | Ubiquitination | ASEDEIKKAYRKRAL CCHHHHHHHHHHHHH | 57.20 | - | |
| 401 | Phosphorylation | EDEIKKAYRKRALMH HHHHHHHHHHHHHHH | 26.08 | 29496907 | |
| 407 | Sulfoxidation | AYRKRALMHHPDRHS HHHHHHHHHCCCCCC | 2.38 | 30846556 | |
| 412 | Methylation | ALMHHPDRHSGASAE HHHHCCCCCCCCCHH | 30.26 | - | |
| 414 | Phosphorylation | MHHPDRHSGASAEVQ HHCCCCCCCCCHHHH | 36.63 | 28555341 | |
| 417 | Phosphorylation | PDRHSGASAEVQKEE CCCCCCCCHHHHHHH | 28.61 | 29449344 | |
| 422 | Ubiquitination | GASAEVQKEEEKKFK CCCHHHHHHHHHHHH | 72.73 | 33845483 | |
| 429 | Ubiquitination | KEEEKKFKEVGEAFT HHHHHHHHHHHHHHH | 61.44 | 33845483 | |
| 442 | 2-Hydroxyisobutyrylation | FTILSDPKKKTRYDS HHHCCCCCCCCCCCC | 72.41 | - | |
| 442 | Ubiquitination | FTILSDPKKKTRYDS HHHCCCCCCCCCCCC | 72.41 | 22817900 | |
| 443 | Ubiquitination | TILSDPKKKTRYDSG HHCCCCCCCCCCCCC | 65.84 | 22817900 | |
| 444 | Ubiquitination | ILSDPKKKTRYDSGQ HCCCCCCCCCCCCCC | 44.34 | 22817900 | |
| 447 | Phosphorylation | DPKKKTRYDSGQDLD CCCCCCCCCCCCCCC | 21.49 | 26434776 | |
| 449 | Phosphorylation | KKKTRYDSGQDLDEE CCCCCCCCCCCCCCC | 29.44 | 25159151 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DNJC7_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DNJC7_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DNJC7_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-50, AND MASSSPECTROMETRY. | |